BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 18698590)

  • 1. Racial disparities in recurrence among patients with early-stage endometrial cancer: is recurrence increased in black patients who receive estrogen replacement therapy?
    Maxwell GL; Tian C; Risinger JI; Hamilton CA; Barakat RR;
    Cancer; 2008 Sep; 113(6):1431-7. PubMed ID: 18698590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial disparity in survival among patients with advanced/recurrent endometrial adenocarcinoma: a Gynecologic Oncology Group study.
    Maxwell GL; Tian C; Risinger J; Brown CL; Rose GS; Thigpen JT; Fleming GF; Gallion HH; Brewster WR;
    Cancer; 2006 Nov; 107(9):2197-205. PubMed ID: 17001661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receipt of adjuvant endometrial cancer treatment according to race: an NRG Oncology/Gynecologic Oncology Group 210 Study.
    Felix AS; Cohn DE; Brasky TM; Zaino R; Park K; Mutch DG; Creasman WT; Thaker PH; Walker JL; Moore RG; Lele SB; Guntupalli SR; Downs LS; Nagel CI; Boggess JF; Pearl ML; Ioffe OB; Randall ME; Brinton LA
    Am J Obstet Gynecol; 2018 Nov; 219(5):459.e1-459.e11. PubMed ID: 30096321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of comorbid conditions on racial disparities in endometrial cancer survival.
    Ruterbusch JJ; Ali-Fehmi R; Olson SH; Sealy-Jefferson S; Rybicki BA; Hensley-Alford S; Elshaikh MA; Gaba AR; Schultz D; Munkarah AR; Cote ML
    Am J Obstet Gynecol; 2014 Dec; 211(6):627.e1-9. PubMed ID: 24954655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of race and histology on patterns of failure in women with early stage endometrial cancer treated with high dose rate brachytherapy.
    Ozen A; Falchook AD; Varia MA; Gehrig P; Jones EL
    Gynecol Oncol; 2015 Aug; 138(2):429-33. PubMed ID: 26024766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Racial disparities in young women with endometrial cancer.
    Mukerji B; Baptiste C; Chen L; Tergas AI; Hou JY; Ananth CV; Neugut AI; Hershman DL; Wright JD
    Gynecol Oncol; 2018 Mar; 148(3):527-534. PubMed ID: 29307452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Racial differences in surgeons and hospitals for endometrial cancer treatment.
    Armstrong K; Randall TC; Polsky D; Moye E; Silber JH
    Med Care; 2011 Feb; 49(2):207-14. PubMed ID: 21150796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Growing Burden of Endometrial Cancer: A Major Racial Disparity Affecting Black Women.
    Cote ML; Ruterbusch JJ; Olson SH; Lu K; Ali-Fehmi R
    Cancer Epidemiol Biomarkers Prev; 2015 Sep; 24(9):1407-15. PubMed ID: 26290568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of quality of care on racial disparities in survival for endometrial cancer.
    Huang AB; Huang Y; Hur C; Tergas AI; Khoury-Collado F; Melamed A; St Clair CM; Hou JY; Ananth CV; Neugut AI; Hershman DL; Wright JD
    Am J Obstet Gynecol; 2020 Sep; 223(3):396.e1-396.e13. PubMed ID: 32109459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endometrial cancer in morbidly obese women: do racial disparities affect surgical or survival outcomes?
    Cote ML; Ruterbusch JJ; Ahmed Q; Bandyopadhyay S; Alosh B; Abdulfatah E; Seward S; Morris R; Ali-Fehmi R
    Gynecol Oncol; 2014 Apr; 133(1):38-42. PubMed ID: 24680590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes among black patients with stage II and III colon cancer receiving chemotherapy: an analysis of ACCENT adjuvant trials.
    Yothers G; Sargent DJ; Wolmark N; Goldberg RM; O'Connell MJ; Benedetti JK; Saltz LB; Dignam JJ; Blackstock AW;
    J Natl Cancer Inst; 2011 Oct; 103(20):1498-506. PubMed ID: 21997132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized double-blind trial of estrogen replacement therapy versus placebo in stage I or II endometrial cancer: a Gynecologic Oncology Group Study.
    Barakat RR; Bundy BN; Spirtos NM; Bell J; Mannel RS;
    J Clin Oncol; 2006 Feb; 24(4):587-92. PubMed ID: 16446331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. More than treatment refusal: a National Cancer Database analysis of adjuvant treatment refusal and racial survival disparities among women with endometrial cancer.
    Barrington DA; Sinnott JA; Nixon D; Padamsee TJ; Cohn DE; Doll KM; Donneyong MM; Felix AS
    Am J Obstet Gynecol; 2022 Aug; 227(2):244.e1-244.e17. PubMed ID: 35283091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in treatment and outcome between African-American and white women with endometrial cancer.
    Randall TC; Armstrong K
    J Clin Oncol; 2003 Nov; 21(22):4200-6. PubMed ID: 14615448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endometrial carcinoma recurrence according to race and ethnicity: An NRG Oncology/Gynecologic Oncology Group 210 Study.
    Felix AS; Brasky TM; Cohn DE; Mutch DG; Creasman WT; Thaker PH; Walker JL; Moore RG; Lele SB; Guntupalli SR; Downs LS; Nagel C; Boggess JF; Pearl ML; Ioffe OB; Deng W; Miller DS; Brinton LA
    Int J Cancer; 2018 Mar; 142(6):1102-1115. PubMed ID: 29063589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of hospital volume on racial disparities and outcomes for endometrial cancer.
    Buskwofie A; Huang Y; Tergas AI; Hou JY; Ananth CV; Neugut AI; Hershman DL; Wright JD
    Gynecol Oncol; 2018 May; 149(2):329-336. PubMed ID: 29506862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy intensity and toxicity among black and white women with advanced and recurrent endometrial cancer: a Gynecologic Oncology Group Study.
    Farley JH; Tian C; Rose GS; Brown CL; Birrer M; Risinger JI; Thigpen JT; Fleming GF; Gallion HH; Maxwell GL
    Cancer; 2010 Jan; 116(2):355-61. PubMed ID: 19924790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of race, comorbid conditions and obesity on survival endpoints in women with high grade endometrial carcinoma.
    Fucinari J; Elshaikh MA; Ruterbusch JJ; Khalil R; Dyson G; Shultz D; Ali-Fehmi R; Cote ML
    Gynecol Oncol; 2021 Jul; 162(1):134-141. PubMed ID: 33985795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Black and Hispanic women are less likely than white women to receive guideline-concordant endometrial cancer treatment.
    Kaspers M; Llamocca E; Quick A; Dholakia J; Salani R; Felix AS
    Am J Obstet Gynecol; 2020 Sep; 223(3):398.e1-398.e18. PubMed ID: 32142825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Racial differences in patients with adenocarcinoma of the endometrium.
    Cronjé HS; Fourie S; Doman MJ; Helms JB; Nel JT; Goedhals L
    Int J Gynaecol Obstet; 1992 Nov; 39(3):213-8. PubMed ID: 1360916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.